Recordati stock: Akros confirms EUR 65.00 target for Recordati stock
Published on 10/16/2026 at 17:44 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSAnalyst target and reporting date
- On October 14, 2026, Akros confirmed a EUR 65.00 target for Recordati.
- Recordati is scheduled to release third-quarter results on November 10, 2026.
- Recordati stock costs EUR 52.95 at Lang & Schwarz on October 16, 2026 at 7:39 p.m. CEST, minus 0.09 percent versus the Xetra close of October 15, 2026.
- Recordati had a EUR 10.8 billion market capitalization and a P/E ratio of 22.26 as of October 16, 2026.
Akros confirmed a EUR 65.00 target for Recordati on October 14, 2026, according to Il Sole 24 Ore. That target stands 22.76 percent above Recordati's EUR 52.95 price. Recordati stock traded at EUR 52.95 at Lang & Schwarz on October 16, 2026 at 7:39 p.m. CEST, minus 0.09 percent versus the Xetra close of October 15, 2026 at EUR 53.00.
Akros target stays above price
The analyst view gives investors a valuation marker beyond the EUR 53.00 tender offer. The same report said Equita had a EUR 69.00 target and Intermonte a EUR 71.00 target, while Bloomberg's consensus stood at EUR 60.10. Those figures place the analyst range above the current market quotation, but they do not change the cash terms of the offer.
Recordati remains near its yearly high
Recordati's 52-week range was EUR 43.76 to EUR 54.45 as of October 16, 2026. The Lang & Schwarz price was 2.75 percent below the upper end of that range. The session's quoted volume was 162,393 shares against an average volume of 338,368 shares, making the reported volume 52.01 percent below its average.
Valuation and November date
Recordati's market capitalization stood at EUR 10.8 billion and its P/E ratio at 22.26 on October 16, 2026. The company had 4,693 employees and operated in around 150 countries, according to its investor-relations page. The next scheduled corporate date is November 10, 2026, when Recordati is listed as due to publish its third-quarter results by MarketScreener.
Comparison with peers
Recordati: minus 0.09 percent, P/E 22.26, market capitalization EUR 10.8 billion
Novartis (SIX, CHF): minus 1.00 percent, P/E 23.09, market capitalization CHF 236.9 billion
Volkswagen (Xetra, EUR): plus 2.96 percent, P/E 6.59, market capitalization EUR 34.5 billion
Price and trading position
Recordati's euro quotation finished below the Xetra close while remaining near the top of its 52-week range. The next reported milestone is the November 10, 2026 results date, while the analyst targets cited above provide the main valuation comparison. The further course of trading is shown by the continuously updated real-time quote of Recordati stock.
Recordati stock at a glance
- Company: Recordati Industria Chimica e Farmaceutica S.p.A.
- ISIN: IT0003828271
- Ticker: REC.MI
- Primary exchange: Borsa Italiana
- Price Lang & Schwarz (as of October 16, 2026, 7:39 p.m. CEST): EUR 52.95
- Change versus Xetra close: minus 0.09 percent
- Xetra close (October 15, 2026): EUR 53.00
- Market capitalization: EUR 10.8 billion (as of October 16, 2026)
- 52-week range: EUR 43.76-EUR 54.45 (as of October 16, 2026)
- Sector / Industry: Healthcare / Medical Pharmaceuticals
Market context: Market report FTSE MIB.
